<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance"
            xmlns="http://www.w3.org/1999/xhtml"
            xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature"
            xmlns:c="http://xbrl.dcca.dk/cmn"
            xmlns:d="http://xbrl.dcca.dk/fsa"
            xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
            xmlns:e="http://xbrl.dcca.dk/gsd"
            xmlns:f="http://xbrl.dcca.dk/arr"
            xmlns:g="http://xbrl.dcca.dk/sob"
            xmlns:h="http://xbrl.dcca.dk/mrv"
            xmlns:link="http://www.xbrl.org/2003/linkbase"
            xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
            xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
            xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
            xmlns:xlink="http://www.w3.org/1999/xlink">
   <link:schemaRef xlink:href="http://archprod.service.eogs.dk/taxonomy/20241001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20241001.xsd"
                   xlink:type="simple"/>
   <xbrli:context id="c1">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c37">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:typedMember dimension="c:IdentificationOfAuditorDimension">
								    <c:auditorIdentifier>
									1
								</c:auditorIdentifier>
							  </xbrldi:typedMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c2">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2023-07-01</xbrli:startDate>
							  <xbrli:endDate>2024-06-30</xbrli:endDate>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c4">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c3">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-06-30</xbrli:instant>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c231">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfIntangibleAssetsDimension">
								d:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c233">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfIntangibleAssetsDimension">
								d:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c232">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfIntangibleAssetsDimension">
								d:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c84">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:LandAndBuildingsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c89">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:LandAndBuildingsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c88">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:LandAndBuildingsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c99">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:FixturesFittingsToolsAndEquipmentMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c101">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:FixturesFittingsToolsAndEquipmentMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c100">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfPropertyPlantAndEquipmentDimension">
								d:FixturesFittingsToolsAndEquipmentMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c119">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c478">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2023-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c121">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c480">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c122">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:SharePremiumMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c484">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2023-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:SharePremiumMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c124">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:SharePremiumMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c486">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:SharePremiumMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c137">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c498">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2023-07-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c138">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c499">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2023-07-01</xbrli:startDate>
							  <xbrli:endDate>2024-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c139">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c500">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-06-30</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="d:ClassesOfEquityDimension">
								d:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c29">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">41912367</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-07-01</xbrli:startDate>
							  <xbrli:endDate>2025-06-30</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:typedMember dimension="c:IdentificationOfMemberOfExecutiveBoardDimension">
								    <c:memberOfBoardIdentifier>
									1
								</c:memberOfBoardIdentifier>
							  </xbrldi:typedMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:unit id="u5">
						<xbrli:measure>iso4217:DKK</xbrli:measure>
					</xbrli:unit>
   <xbrli:unit id="u7">
						<xbrli:measure>xbrli:pure</xbrli:measure>
					</xbrli:unit>
   <e:InformationOnTypeOfSubmittedReport contextRef="c1">Årsrapport</e:InformationOnTypeOfSubmittedReport>
   <e:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c1" id="ParaIndex_14148_CellNumber_XB1.C3_CellInstance_0">34209936</e:IdentificationNumberCvrOfSubmittingEnterprise>
   <e:NameOfSubmittingEnterprise contextRef="c1" id="ParaIndex_14153_CellNumber_XB1.C4_CellInstance_0">Grant Thornton, Godkendt Revisionspartnerselskab</e:NameOfSubmittingEnterprise>
   <e:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c1" id="ParaIndex_14158_CellNumber_XB1.C5_CellInstance_0">Lautrupsgade, 11</e:AddressOfSubmittingEnterpriseStreetAndNumber>
   <e:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c1" id="ParaIndex_14163_CellNumber_XB1.C6_CellInstance_0">2100, København Ø</e:AddressOfSubmittingEnterprisePostcodeAndTown>
   <e:PrecedingReportingPeriodStartDate contextRef="c1">2023-07-01</e:PrecedingReportingPeriodStartDate>
   <e:PredingReportingPeriodEndDate contextRef="c1">2024-06-30</e:PredingReportingPeriodEndDate>
   <e:ReportingPeriodStartDate contextRef="c1">2024-07-01</e:ReportingPeriodStartDate>
   <e:ReportingPeriodEndDate contextRef="c1">2025-06-30</e:ReportingPeriodEndDate>
   <e:IdentificationNumberCvrOfReportingEntity contextRef="c1" id="ParaIndex_14193_CellNumber_XB1.C12_CellInstance_0">41912367</e:IdentificationNumberCvrOfReportingEntity>
   <e:NameOfReportingEntity contextRef="c1" id="ParaIndex_14208_CellNumber_XB1.C15_CellInstance_0">Nature's BioCeuticals Denmark ApS</e:NameOfReportingEntity>
   <e:AddressOfReportingEntityStreetName contextRef="c1" id="ParaIndex_14213_CellNumber_XB1.C16_CellInstance_0">Lautrupsgade</e:AddressOfReportingEntityStreetName>
   <e:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c1" id="ParaIndex_14218_CellNumber_XB1.C17_CellInstance_0">7</e:AddressOfReportingEntityStreetBuildingIdentifier>
   <e:AddressOfReportingEntityPostCodeIdentifier contextRef="c1" id="ParaIndex_14223_CellNumber_XB1.C18_CellInstance_0">2100</e:AddressOfReportingEntityPostCodeIdentifier>
   <e:AddressOfReportingEntityDistrictName contextRef="c1" id="ParaIndex_14228_CellNumber_XB1.C19_CellInstance_0">København Ø</e:AddressOfReportingEntityDistrictName>
   <c:NameOfAuditFirm contextRef="c37" id="ParaIndex_14333_CellNumber_XB1.C40_CellInstance_0">Grant Thornton, Godkendt Revisionspartnerselskab</c:NameOfAuditFirm>
   <c:IdentificationNumberCvrOfAuditFirm contextRef="c37" id="ParaIndex_14340_CellNumber_XB1.C41_CellInstance_0">34209936</c:IdentificationNumberCvrOfAuditFirm>
   <c:NameAndSurnameOfAuditor contextRef="c37" id="ParaIndex_14347_CellNumber_XB1.C42_CellInstance_0">Michael Beuchert</c:NameAndSurnameOfAuditor>
   <c:DescriptionOfAuditor contextRef="c37" id="ParaIndex_14354_CellNumber_XB1.C43_CellInstance_0">statsautoriseret revisor</c:DescriptionOfAuditor>
   <c:IdentificationNumberOfAuditor contextRef="c37" id="ParaIndex_14361_CellNumber_XB1.C44_CellInstance_0">mne32794</c:IdentificationNumberOfAuditor>
   <e:AddressOfAuditorStreetName contextRef="c37" id="ParaIndex_14366_CellNumber_XB1.C45_CellInstance_0">Lautrupsgade</e:AddressOfAuditorStreetName>
   <e:AddressOfAuditorStreetBuildingIdentifier contextRef="c37" id="ParaIndex_14371_CellNumber_XB1.C46_CellInstance_0">11</e:AddressOfAuditorStreetBuildingIdentifier>
   <e:AddressOfAuditorPostCodeIdentifier contextRef="c37" id="ParaIndex_14376_CellNumber_XB1.C47_CellInstance_0">2100</e:AddressOfAuditorPostCodeIdentifier>
   <e:AddressOfAuditorDistrictName contextRef="c37" id="ParaIndex_14381_CellNumber_XB1.C48_CellInstance_0">København Ø</e:AddressOfAuditorDistrictName>
   <e:AddressOfAuditorCountry contextRef="c37" id="ParaIndex_14386_CellNumber_XB1.C49_CellInstance_0">Danmark</e:AddressOfAuditorCountry>
   <e:TelephoneNumberOfAuditor contextRef="c37" id="ParaIndex_14391_CellNumber_XB1.C50_CellInstance_0">+45 33 110 220</e:TelephoneNumberOfAuditor>
   <e:EmailOfAuditor contextRef="c1" id="ParaIndex_14396_CellNumber_XB1.C51_CellInstance_0">info@dk.gt.com</e:EmailOfAuditor>
   <e:DateOfGeneralMeeting contextRef="c1">2026-01-19</e:DateOfGeneralMeeting>
   <e:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c1" id="ParaIndex_14406_CellNumber_XB1.C53_CellInstance_0">Francois Jean-Martin Susini</e:NameAndSurnameOfChairmanOfGeneralMeeting>
   <d:ClassOfReportingEntity contextRef="c1">Regnskabsklasse B</d:ClassOfReportingEntity>
   <c:TypeOfAuditorAssistance contextRef="c1" id="ParaIndex_14426_CellNumber_XB1.C57_CellInstance_0">Andre erklæringer uden sikkerhed</c:TypeOfAuditorAssistance>
   <d:StatementOfChangesInEquity contextRef="c1" id="ParaIndex_14431_CellNumber_XB1.C58_CellInstance_0">Ja</d:StatementOfChangesInEquity>
   <e:ToolForPreparingTheXBRLInstanceDocument contextRef="c1" id="ParaIndex_14436_CellNumber_XB1.C59_CellInstance_0">CaseWare fra Revisorgruppen Danmark</e:ToolForPreparingTheXBRLInstanceDocument>
   <f:AddresseeOfAuditorsReportOnOtherReport contextRef="c1" id="ParaIndex_14453_CellNumber_XB0.D3_CellInstance_0">anpartshaverne</f:AddresseeOfAuditorsReportOnOtherReport>
   <f:SignatureOfAuditorsPlace contextRef="c1" id="ParaIndex_14458_CellNumber_XB0.D4_CellInstance_0">København</f:SignatureOfAuditorsPlace>
   <f:SignatureOfAuditorsDate contextRef="c1">2026-01-19</f:SignatureOfAuditorsDate>
   <g:PlaceOfSignatureOfStatement contextRef="c1" id="ParaIndex_14503_CellNumber_XB0.D13_CellInstance_0">København Ø</g:PlaceOfSignatureOfStatement>
   <g:DateOfApprovalOfAnnualReport contextRef="c1">2026-01-19</g:DateOfApprovalOfAnnualReport>
   <d:GrossProfitLoss contextRef="c1" decimals="0" unitRef="u5">-129477</d:GrossProfitLoss>
   <d:GrossProfitLoss contextRef="c2" decimals="0" unitRef="u5">-400403</d:GrossProfitLoss>
   <d:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c1" decimals="0" unitRef="u5">477244</d:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
   <d:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c2" decimals="0" unitRef="u5">477244</d:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
   <d:ProfitLossFromOrdinaryOperatingActivities contextRef="c1" decimals="0" unitRef="u5">-606721</d:ProfitLossFromOrdinaryOperatingActivities>
   <d:ProfitLossFromOrdinaryOperatingActivities contextRef="c2" decimals="0" unitRef="u5">-877647</d:ProfitLossFromOrdinaryOperatingActivities>
   <d:OtherFinanceExpenses contextRef="c1" decimals="0" unitRef="u5">4303</d:OtherFinanceExpenses>
   <d:OtherFinanceExpenses contextRef="c2" decimals="0" unitRef="u5">20002</d:OtherFinanceExpenses>
   <d:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c1" decimals="0" unitRef="u5">-611024</d:ProfitLossFromOrdinaryActivitiesBeforeTax>
   <d:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c2" decimals="0" unitRef="u5">-897649</d:ProfitLossFromOrdinaryActivitiesBeforeTax>
   <d:ProfitLoss contextRef="c1" decimals="0" unitRef="u5">-611024</d:ProfitLoss>
   <d:ProfitLoss contextRef="c2" decimals="0" unitRef="u5">-897649</d:ProfitLoss>
   <d:TransferredToFromRetainedEarnings contextRef="c1" decimals="0" unitRef="u5">-611024</d:TransferredToFromRetainedEarnings>
   <d:TransferredToFromRetainedEarnings contextRef="c2" decimals="0" unitRef="u5">-897649</d:TransferredToFromRetainedEarnings>
   <d:AcquiredIntangibleAssets contextRef="c4" decimals="0" unitRef="u5">150000</d:AcquiredIntangibleAssets>
   <d:AcquiredIntangibleAssets contextRef="c3" decimals="0" unitRef="u5">160000</d:AcquiredIntangibleAssets>
   <d:IntangibleAssets contextRef="c4" decimals="0" unitRef="u5">150000</d:IntangibleAssets>
   <d:IntangibleAssets contextRef="c3" decimals="0" unitRef="u5">160000</d:IntangibleAssets>
   <d:LandAndBuildings contextRef="c4" decimals="0" unitRef="u5">12628800</d:LandAndBuildings>
   <d:LandAndBuildings contextRef="c3" decimals="0" unitRef="u5">12881600</d:LandAndBuildings>
   <d:FixturesFittingsToolsAndEquipment contextRef="c4" decimals="0" unitRef="u5">214444</d:FixturesFittingsToolsAndEquipment>
   <d:FixturesFittingsToolsAndEquipment contextRef="c3" decimals="0" unitRef="u5">428888</d:FixturesFittingsToolsAndEquipment>
   <d:PropertyPlantAndEquipment contextRef="c4" decimals="0" unitRef="u5">12843244</d:PropertyPlantAndEquipment>
   <d:PropertyPlantAndEquipment contextRef="c3" decimals="0" unitRef="u5">13310488</d:PropertyPlantAndEquipment>
   <d:LongtermReceivablesFromOwnersAndManagement contextRef="c4" decimals="0" unitRef="u5">0</d:LongtermReceivablesFromOwnersAndManagement>
   <d:LongtermReceivablesFromOwnersAndManagement contextRef="c3" decimals="0" unitRef="u5">108062</d:LongtermReceivablesFromOwnersAndManagement>
   <d:LongtermInvestmentsAndReceivables contextRef="c4" decimals="0" unitRef="u5">0</d:LongtermInvestmentsAndReceivables>
   <d:LongtermInvestmentsAndReceivables contextRef="c3" decimals="0" unitRef="u5">108062</d:LongtermInvestmentsAndReceivables>
   <d:NoncurrentAssets contextRef="c4" decimals="0" unitRef="u5">12993244</d:NoncurrentAssets>
   <d:NoncurrentAssets contextRef="c3" decimals="0" unitRef="u5">13578550</d:NoncurrentAssets>
   <d:OtherShorttermReceivables contextRef="c4" decimals="0" unitRef="u5">119357</d:OtherShorttermReceivables>
   <d:OtherShorttermReceivables contextRef="c3" decimals="0" unitRef="u5">92029</d:OtherShorttermReceivables>
   <d:ShorttermReceivables contextRef="c4" decimals="0" unitRef="u5">119357</d:ShorttermReceivables>
   <d:ShorttermReceivables contextRef="c3" decimals="0" unitRef="u5">92029</d:ShorttermReceivables>
   <d:CashAndCashEquivalents contextRef="c4" decimals="0" unitRef="u5">100</d:CashAndCashEquivalents>
   <d:CashAndCashEquivalents contextRef="c3" decimals="0" unitRef="u5">100</d:CashAndCashEquivalents>
   <d:CurrentAssets contextRef="c4" decimals="0" unitRef="u5">119457</d:CurrentAssets>
   <d:CurrentAssets contextRef="c3" decimals="0" unitRef="u5">92129</d:CurrentAssets>
   <d:Assets contextRef="c4" decimals="0" unitRef="u5">13112701</d:Assets>
   <d:Assets contextRef="c3" decimals="0" unitRef="u5">13670679</d:Assets>
   <d:RecognisedButNotOwnedAssets contextRef="c1" decimals="0" unitRef="u5">0</d:RecognisedButNotOwnedAssets>
   <d:ContributedCapital contextRef="c4" decimals="0" unitRef="u5">1600000</d:ContributedCapital>
   <d:ContributedCapital contextRef="c3" decimals="0" unitRef="u5">1600000</d:ContributedCapital>
   <d:SharePremium contextRef="c4" decimals="0" unitRef="u5">180000</d:SharePremium>
   <d:SharePremium contextRef="c3" decimals="0" unitRef="u5">180000</d:SharePremium>
   <d:RetainedEarnings contextRef="c4" decimals="0" unitRef="u5">10371659</d:RetainedEarnings>
   <d:RetainedEarnings contextRef="c3" decimals="0" unitRef="u5">10982683</d:RetainedEarnings>
   <d:Equity contextRef="c4" decimals="0" unitRef="u5">12151659</d:Equity>
   <d:Equity contextRef="c3" decimals="0" unitRef="u5">12762683</d:Equity>
   <d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsLongterm contextRef="c4" decimals="0" unitRef="u5">912851</d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsLongterm>
   <d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsLongterm contextRef="c3" decimals="0" unitRef="u5">860349</d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsLongterm>
   <d:LongtermLiabilitiesOtherThanProvisions contextRef="c4" decimals="0" unitRef="u5">912851</d:LongtermLiabilitiesOtherThanProvisions>
   <d:LongtermLiabilitiesOtherThanProvisions contextRef="c3" decimals="0" unitRef="u5">860349</d:LongtermLiabilitiesOtherThanProvisions>
   <d:ShorttermTradePayables contextRef="c4" decimals="0" unitRef="u5">30350</d:ShorttermTradePayables>
   <d:ShorttermTradePayables contextRef="c3" decimals="0" unitRef="u5">29806</d:ShorttermTradePayables>
   <d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsShortterm contextRef="c4" decimals="0" unitRef="u5">17841</d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsShortterm>
   <d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsShortterm contextRef="c3" decimals="0" unitRef="u5">17841</d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsShortterm>
   <d:ShorttermLiabilitiesOtherThanProvisions contextRef="c4" decimals="0" unitRef="u5">48191</d:ShorttermLiabilitiesOtherThanProvisions>
   <d:ShorttermLiabilitiesOtherThanProvisions contextRef="c3" decimals="0" unitRef="u5">47647</d:ShorttermLiabilitiesOtherThanProvisions>
   <d:LiabilitiesOtherThanProvisions contextRef="c4" decimals="0" unitRef="u5">961042</d:LiabilitiesOtherThanProvisions>
   <d:LiabilitiesOtherThanProvisions contextRef="c3" decimals="0" unitRef="u5">907996</d:LiabilitiesOtherThanProvisions>
   <d:LiabilitiesAndEquity contextRef="c4" decimals="0" unitRef="u5">13112701</d:LiabilitiesAndEquity>
   <d:LiabilitiesAndEquity contextRef="c3" decimals="0" unitRef="u5">13670679</d:LiabilitiesAndEquity>
   <d:AverageNumberOfEmployees contextRef="c1" decimals="INF" unitRef="u7">1</d:AverageNumberOfEmployees>
   <d:AverageNumberOfEmployees contextRef="c2" decimals="INF" unitRef="u7">1</d:AverageNumberOfEmployees>
   <d:OtherInterestExpenses contextRef="c1" decimals="0" unitRef="u5">4303</d:OtherInterestExpenses>
   <d:OtherInterestExpenses contextRef="c2" decimals="0" unitRef="u5">20002</d:OtherInterestExpenses>
   <d:OtherFinanceExpenses contextRef="c1" decimals="0" unitRef="u5">4303</d:OtherFinanceExpenses>
   <d:OtherFinanceExpenses contextRef="c2" decimals="0" unitRef="u5">20002</d:OtherFinanceExpenses>
   <d:IntangibleAssetsGross contextRef="c231" decimals="0" unitRef="u5">170000</d:IntangibleAssetsGross>
   <d:IntangibleAssetsGross contextRef="c233" decimals="0" unitRef="u5">170000</d:IntangibleAssetsGross>
   <d:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c231" decimals="0" unitRef="u5">10000</d:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <d:AmortisationOfIntangibleAssets contextRef="c232" decimals="0" unitRef="u5">10000</d:AmortisationOfIntangibleAssets>
   <d:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c233" decimals="0" unitRef="u5">20000</d:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <d:IntangibleAssets contextRef="c233" decimals="0" unitRef="u5">150000</d:IntangibleAssets>
   <d:PropertyPlantAndEquipmentGross contextRef="c84" decimals="0" unitRef="u5">13640000</d:PropertyPlantAndEquipmentGross>
   <d:PropertyPlantAndEquipmentGross contextRef="c89" decimals="0" unitRef="u5">13640000</d:PropertyPlantAndEquipmentGross>
   <d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c84" decimals="0" unitRef="u5">758400</d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <d:DepreciationOfPropertyPlantAndEquipment contextRef="c88" decimals="0" unitRef="u5">252800</d:DepreciationOfPropertyPlantAndEquipment>
   <d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c89" decimals="0" unitRef="u5">1011200</d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <d:PropertyPlantAndEquipment contextRef="c89" decimals="0" unitRef="u5">12628800</d:PropertyPlantAndEquipment>
   <d:PropertyPlantAndEquipmentGross contextRef="c99" decimals="0" unitRef="u5">1072220</d:PropertyPlantAndEquipmentGross>
   <d:PropertyPlantAndEquipmentGross contextRef="c101" decimals="0" unitRef="u5">1072220</d:PropertyPlantAndEquipmentGross>
   <d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c99" decimals="0" unitRef="u5">643332</d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <d:DepreciationOfPropertyPlantAndEquipment contextRef="c100" decimals="0" unitRef="u5">214444</d:DepreciationOfPropertyPlantAndEquipment>
   <d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c101" decimals="0" unitRef="u5">857776</d:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <d:PropertyPlantAndEquipment contextRef="c101" decimals="0" unitRef="u5">214444</d:PropertyPlantAndEquipment>
   <d:Equity contextRef="c119" decimals="0" unitRef="u5">1600000</d:Equity>
   <d:Equity contextRef="c478" decimals="0" unitRef="u5">1600000</d:Equity>
   <d:Equity contextRef="c121" decimals="0" unitRef="u5">1600000</d:Equity>
   <d:Equity contextRef="c480" decimals="0" unitRef="u5">1600000</d:Equity>
   <d:Equity contextRef="c122" decimals="0" unitRef="u5">180000</d:Equity>
   <d:Equity contextRef="c484" decimals="0" unitRef="u5">180000</d:Equity>
   <d:Equity contextRef="c124" decimals="0" unitRef="u5">180000</d:Equity>
   <d:Equity contextRef="c486" decimals="0" unitRef="u5">180000</d:Equity>
   <d:Equity contextRef="c137" decimals="0" unitRef="u5">10982683</d:Equity>
   <d:Equity contextRef="c498" decimals="0" unitRef="u5">-2932050</d:Equity>
   <d:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies contextRef="c138" decimals="0" unitRef="u5">0</d:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies>
   <d:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies contextRef="c499" decimals="0" unitRef="u5">14812382</d:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies>
   <d:ProfitLoss contextRef="c138" decimals="0" unitRef="u5">-611024</d:ProfitLoss>
   <d:ProfitLoss contextRef="c499" decimals="0" unitRef="u5">-897649</d:ProfitLoss>
   <d:Equity contextRef="c139" decimals="0" unitRef="u5">10371659</d:Equity>
   <d:Equity contextRef="c500" decimals="0" unitRef="u5">10982683</d:Equity>
   <g:IdentificationOfApprovedAnnualReport contextRef="c1" id="ParaIndex_35272" xml:lang="en">Today, the Managing Director has approved the annual report of Nature's BioCeuticals Denmark ApS for the financial year 1 July 2024 - 30 June 2025.
												
											</g:IdentificationOfApprovedAnnualReport>
   <g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" id="ParaIndex_35332" xml:lang="en">The annual report has been prepared in accordance with the Danish Financial Statements Act.
												
											</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement>
   <g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" id="ParaIndex_35376" xml:lang="en">I consider the chosen accounting policy to be appropriate, and in my opinion, the financial statements give a true and fair view of the financial position of the Company at 30 June 2025 and of the results of the Company's operations for the financial year 1 July 2024 – 30 June 2025.
												
											</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults>
   <g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing contextRef="c1" id="ParaIndex_35452" xml:lang="en">The Managing Director consider the conditions for audit exemption of the 2024/25 financial statements to be met.
												
											</g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing>
   <g:ManagementsStatementAboutManagementsReview contextRef="c1" id="ParaIndex_35468" xml:lang="en">Further, in my opinion, the Management's review gives a true and fair review of the matters discussed in the Management's review.
												
											</g:ManagementsStatementAboutManagementsReview>
   <g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" id="ParaIndex_35484" xml:lang="en">We recommend that the annual report be approved at the Annual General Meeting.
												
											</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting>
   <c:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c29" id="ParaIndex_35622_CellNumber_DI1.A2_CellInstance_0">Francois Jean-Martin Susini</c:NameAndSurnameOfMemberOfExecutiveBoard>
   <f:DescriptionOfOtherEngagement contextRef="c1" id="ParaIndex_44590" xml:lang="en">We have compiled the financial statements of Nature's BioCeuticals Denmark ApS for the financial year 1 July 2024 - 30 June 2025 based on the company's bookkeeping and on information you have provided.
												
											These financial statements comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies.
												
											We performed this compilation engagement in accordance with International Standard on Related Services 4410 (Revised), Compilation Engagements.
												
											We have applied our expertise in accounting and financial reporting to assist Management in the preparation and presentation of these financial statements in accordance with the Danish Financial Statements Act. We have complied with relevant requirements under the Danish Act on Approved Auditors and Audit Firms and International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) including principles of integrity, objectivity, professional competence and due care.
												
											These financial statements and the accuracy and completeness of the information used to compile them are your responsibility.
												
											Since a compilation engagement is not an assurance engagement, we are not required to verify the accuracy or completeness of the information you provided to us to compile these financial statements. Accordingly, we do not express an audit opinion or a review conclusion on whether these financial statements are prepared in accordance with the Danish Financial Statements Act.
												
											</f:DescriptionOfOtherEngagement>
   <h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" id="ParaIndex_46291" xml:lang="en">Description of key activities of the companyLike previous years, the key activities comprise trading and production of medical cannabis and associated activities
												
											</h:DescriptionOfPrimaryActivitiesOfEntity>
   <h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" id="ParaIndex_46599" xml:lang="en">Significant changes in the company's activities and financial mattersThere have been no significant changes in activities and financial matters.
												
											The gross loss for the year totals DKK -129.477 against DKK -400.403 last year. Profit or loss from ordinary activities after tax totals DKK -611.024 against DKK -897.649 last year. Management considers the net profit or loss for the year satisfactory.
												
											Material errors in previous yearsDuring the financial year 2024/25, management has identified significant income related to the financial year 2023/24. This affects the previously issued annual report for 2023/24. As a result, the error has been corrected as a prior period adjustment by restating the comparative figues and the opening equity in the financial statements for 2024/25. For further description of the effect of the correction, reference is made to the company´s accounting policies.
												
											</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs>
   <d:DisclosureOfUncertaintiesRelatingToGoingConcern contextRef="c1" id="ParaIndex_82912" xml:lang="en">1.Uncertainties relating to going concernThe company has received a letter of support from its investors, why the accounts have been prepared on a going concern basis.
												
											
												
											
								
							</d:DisclosureOfUncertaintiesRelatingToGoingConcern>
   <d:InformationOnReportingClassOfEntity contextRef="c1" id="ParaIndex_113853" xml:lang="en">The annual report for Nature's BioCeuticals Denmark ApS has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises.
												
											The accounting policies are unchanged from last year, and the annual report is presented in DKK.
												
											</d:InformationOnReportingClassOfEntity>
   <d:ExplanationOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors contextRef="c1" id="ParaIndex_114646" xml:lang="en">Material errors in previous yearsDuring the financial year 2024/25, management identified a significant error related to other long term payables concerning previous financial year. The error relates to first time recognition on land and buildings.
													
													 Management has decided to correct the error in the financial statements for 2024/25 with correction of the comparative figures and opening equity.
												
											The correction retaled to other long term payables results in a positive impact of DKK 14.812 thousand on the other long term payables line item in the balance sheet and an equivalent positive impact on the equity.
												
											Accordingly, the error has been corrected as a prior period adjustment, with a correction of the comparative figures and the opening equity in the financial statements for 2024/25.
												
											</d:ExplanationOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" id="ParaIndex_118005" xml:lang="en">Gross lossGross loss comprises external costs.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" id="ParaIndex_119097" xml:lang="en">Other external expenses include administrative costs
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses>
   <d:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" id="ParaIndex_119425" xml:lang="en">Depreciation, amortisation, and write-down for impairmentDepreciation, amortisation, and write-down for impairment comprise depreciation on, amortisation of, and write-down for impairment of intangible and tangible assets, respectively.
												
											</d:DescriptionOfMethodsOfImpairmentLossesAndDepreciation>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" id="ParaIndex_119765" xml:lang="en">Financial income and expensesFinancial income and expenses are recognised in the income statement with the amounts concerning the financial year. Financial income and expenses comprise interest income and expenses, financial expenses from financial leasing, realised and unrealised capital gains and losses relating to securities, debt and transactions in foreign currency, amortisation of financial assets and liabilities as well as surcharges and reimbursements under the advance tax scheme, etc.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" id="ParaIndex_119803" xml:lang="en">
												
											The tax for the year, whichc consists of the current tax for the year and changes in deferred tax, is recognised in the Income Statement by the share that may be attributed to the profit of the year, and is recognised directly in equity by the share that may be attributed to entries directly to equity.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets contextRef="c1" id="ParaIndex_119945" xml:lang="en">
												
											Intangible fixed assetsPatents and licenses are measured at the lower of cost less accumulated amortisaton and the recoverable amount. Patents are amortised over the remaining patent period and licenses are amortised over the period of the agreement, however, no more tan 8 year.
													
													
													Profit or loss from sale of intangible fixed assets is calculated at the difference between the sale price and the carrying amount at the time of the sale. Profit and loss are recognised in the Income Statement under other operating income or other operating expenses.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" id="ParaIndex_120289" xml:lang="en">Property, plant, and equipmentProperty, plant, and equipment are measured at cost less accrued depreciation and write-down for impairment. Land is not subject to depreciation.
												
											The depreciable amount is cost less any expected residual value after the end of the useful life of the asset. The amortisation period and the residual value are determined at the acquisition date and reassessed annually. If the residual value exceeds the carrying amount, the depreciation is discontinued.
												
											Depreciation is done on a straight-line basis according to an assessment of the expected useful life and the residual value of the individual assets:
												
											Useful lifeResidual valueOther fixtures and fittings, tools and equipment3-5years0-20 %
												
											Minor assets with an expected useful life of less than 1 year are recognised as costs in the income statement in the year of acquisition.
												
											Profit or loss derived from the disposal of property, land, and equipment is measured as the difference between the sales price less selling costs and the carrying amount at the date of disposal. Profit or loss is recognised in the income statement as other operating income or other operating expenses.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment>
   <d:DescriptionOfMethodsOfLeases contextRef="c1" id="ParaIndex_121084" xml:lang="en">LeasesThe enterprise will be applying IAS 17 as its base of interpretation for recognition of classification and recognition of leases.
												
											At their initial recognition in the statement of financial position, leases concerning property, plant, and equipment where the company holds all essential risks and advantages associated with the proprietary right (finance lease) are measured either at fair value of the asset being leased or at the present value of the future lease payments, whichever value is lower. When calculating the present value, the discount rate used is the internal rate of return of the lease or, alternatively, the borrowing rate of the enterprise. Hereafter, assets held under a finance lease are treated in the same way as other similar property, plant, and equipment.
												
											The capitalised residual lease commitment is recognised in the statement of financial position as a liability other than provisions, and the interest part of the lease is recognised in the income statement for the term of the contract.
												
											All other leases are regarded as operating leases. Payments in connection with operating leases and other lease agreements are recognised in the income statement for the term of the contract. The company's total liabilities concerning operating leases and lease agreements are recognised under contingencies, etc.
												
											</d:DescriptionOfMethodsOfLeases>
   <d:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" id="ParaIndex_122898" xml:lang="en">Impairment loss relating to non-current assetsThe carrying amount of both intangible and tangible fixed assets are subject to annual impairment tests in order to disclose any indications of impairment beyond those expressed by amortisation and depreciation respectively.
												
											If indications of impairment are disclosed, impairment tests are carried out for each individual asset or group of assets, respectively. write-down for impairment is done to the recoverable amount if this value is lower than the carrying amount.
												
											The recoverable amount is the higher value of value in use and selling price less expected selling cost. The value in use is calculated as the present value of the expected net cash flows from the use of the asset or the asset group and expected net cash flows from the sale of the asset or the asset group after the end of their useful life.
												
											Previously recognised impairment losses are reversed when conditions for impairment no longer exist. Impairment relating to goodwill is not reversed.
												
											</d:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" id="ParaIndex_123302" xml:lang="en">ReceivablesReceivables are measured at amortised cost, which usually corresponds to nominal value.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" id="ParaIndex_123765" xml:lang="en">Cash and cash equivalentsCash and cash equivalents comprise cash at bank and on hand.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity contextRef="c1" id="ParaIndex_123803" xml:lang="en">EquityShare premiumShare premium comprises premium payments made in connection with the issue of shares. Costs incurred for carrying through an issue are deducted from the premium.
												
											The premium reserve can be used for dividend, for issuing bonus shares, and for covering losses.
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity>
   <d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" id="ParaIndex_124731" xml:lang="en">LiabilitiesFinancial liabilities are recognised at the time of borrowing by the amount of proceed received less transaction costs. In subsequent periods, the financial liabilities are measured at amortised cost equal to the capitalised value when using the effective interest, the difference between the proceeds and the nominal value being recognised in the Income Statement over the loan period.
													
													
													The amortised cost of the current liabilities corresponds usually to the nominal value. 
												
											</d:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions>
</xbrli:xbrl>
